logo-loader
viewAccenture

Accenture To Acquire German Software Company CAS

laptop350_4ce6c29d4494a.jpg

Consulting firm Accenture (NYSE:ACN) said today that it has agreed to acquire CAS Computer Anwendungs-und Systemberatung AG, a software and consultancy company based in Kaiserslautern, Germany.


Terms of the transaction were not disclosed.


Through its 234 consultants and software developers, CAS provides customer relationship management software for the consumer products industry.  The firm also provides software for retail execution and trade promotions. 


Some of CAS’ customers include Coca Cola (NYSE:KO), Campbell’s (NYSE:CPB), and Pepsico (NYSE:PEP).


CAS said it has been responsible for more than 200 software implementations in 30 countries. 


The deal will help expand the product offering of Accenture’s software division, which currently has more than 40 software products. 


Accenture said it will continue to use the CAS software product name and will manage the product suite within the Accenture Software business.


Subject to customary closing conditions, the deal is expected to close within 60 days.


Recently, Accenture also acquired Knowledge Rules, a Philadelphia-based consulting company that provides business solutions using Pegasystems Business Process Management software.

Quick facts: Accenture

Price: 200.21 USD

NYSE:ACN
Market: NYSE
Market Cap: $127.19 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tonix Pharmaceuticals CEO talks through recent pre-clinical and clinical...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman sat down with Proactive at the BIO CEO & investor Conference in New York. Lederman says the biopharma company had recently unveiled the pre-clinical results of TNX-801, its live virus horsepox vaccine that prevents...

4 hours, 22 minutes ago

2 min read